Corpus Intelligence IC Memo — SPRINGHILL MEMORIAL HOSPITAL 2026-04-26 03:50 UTC
IC Memo — SPRINGHILL MEMORIAL HOSPITAL
Investment Committee Memorandum | AL | 179 beds | Grade C | EBITDA uplift $15.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SPRINGHILL MEMORIAL HOSPITAL

CCN 010144 | MOBILE, AL | 179 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SPRINGHILL MEMORIAL HOSPITAL is a 179-bed suburban community hospital in MOBILE, AL with $216.2M in net patient revenue and a -3.8% operating margin. The hospital serves a payer mix of 20.6% Medicare, 9.9% Medicaid, and 69.5% commercial.

Thesis: Undervalued. Our ML models identify $15.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.8% to 3.6% (+736bps).

Net Revenue HCRIS$216.2M
Current EBITDA COMPUTED$-8.1M
Operating Margin COMPUTED-3.8%
Occupancy HCRIS77.8%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS31.2%
Distress Probability ML43.2%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
36
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -3.8% places it above the state median. Among 36 size-comparable peers (90-358 beds), the median margin is -4.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (90-358), prioritizing same-state peers. 36 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SPRINGHILL MEMORIAL HOSPITAL (Target)AL179$216.2M-3.8%
THE CHILDRENS HOSPITAL OF ALABAL351$839.5M5.8%
BAPTIST MEDICAL CENTER SOUTHAL348$595.4M-4.8%
SOUTHEAST HEALTH MEDICAL CENTEAL353$427.1M-4.4%
EAST ALABAMA MEDICAL CENTERAL297$399.6M-6.5%
USA HEALTH UNIVERSITY HOSPITALAL242$348.5M-6.4%
JACKSON HOSPITAL AND CLINIC IAL278$301.4M-10.4%
NORTH ALABAMA MEDICAL CENTERAL223$259.5M0.5%
CRESTWOOD MEDICAL CENTERAL164$258.9M14.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.5M+210bp18mo
Cost to Collect4.5%2.5%$4.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.6M+122bp9mo
Clean Claim Rate88.0%96.0%$138K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.5M
Cost to Collect
$4.3M
Denial Rate Reduction
$4.3M
A/R Days Reduction
$2.6M
Clean Claim Rate
$138K
Total EBITDA Uplift$15.9M
Current EBITDA$-8.1M
+ RCM Uplift+$15.9M
Pro Forma EBITDA$7.8M
Current Margin-3.8%
Pro Forma Margin3.6%
WC Released (1x)$8.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.5M$105.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.5M$111.9M0.00x-100.0%
Bull Case9.0x11.0x$-11.3M$160.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.3M$171.6M0.00x-100.0%
Bear Case11.0x10.0x$-13.8M$29.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.8M$28.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 36 hospitals with 90-358 beds
  • Same-state prioritization (n=37)
  • Comp margins: P25=-10.0% / P50=-4.6% / P75=3.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.